Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1α and interferon-α but not other cytokines in human immunoglobulin preparations

Immunology

Volumn 99, Issue 1, 2000, Pages 113-123

  Wadhwa, M ^a   Meager, A ^a   Dilger, P ^a   Bird, C ^a   Dolman, C ^a   Das, R G ^a   Thorpe, R ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN FRAGMENT; INTERLEUKIN 1; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ARTICLE; ASSAY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOTHERAPY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BIOLOGICAL ASSAY; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-ALPHA; INTERLEUKIN-1; PROTEIN BINDING;

EID: 0033984950     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00949.x     Document Type: Article

References (35)

1. 1. Ross C., Hansen M.B., Schyberg T. & Berg K. (1990) Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors. Clin Exp Immunol 82, 57.
2. 2. Svenson M., Hansen M.B. & Bendtzen K. (1990) Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera. Scand J Immunol 32, 695.
3. 3. Monti E., Pozzi A., Tiberio L. et al. (1993) Purification of interleukin-2 antibodies from healthy individuals. Immunol Lett 36, 261.
4. 4. Hansen M.B., Svenson M., Diamant M. & Bendtzen K. (1993) High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 5, 72.
5. 5. Jouvenne P., Fossiez F., Garrone P. et al. (1996) Increased incidence of neutralizing autoantibodies against interleukin-1 alpha (IL-1 alpha) in nondestructive chronic polyarthritis. J Clin Immunol 16, 283.
6. 6. Kurdowska A., Miller E.J., Noble J.M. et al. (1996) Anti-TL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 157, 2699.
7. 7. Amiral J., Marfaing-Koka A., Wolf M. et al. (1996) Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88, 410.
8. 8. Menetrier-Caux C., Briere F., Jouvenne P. et al. (1996) Identification of human IgG autoantibodies specific for IL-10. Clin Exp Immunol 104, 173.
9. 9. Panem S., Check I.J., Henriksen D. & Vilcek J. (1982) Antibodies to alpha-interferon in a patient with systemic lupus crythematosus. J Immunol 129, 1.
10. 10. Suit B.E., Axelrod D., Moutsopoulos H.M., Decker J.L. & Hooks J.J. (1983) Detection of anti-interferon antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1, 133.
11. 11. Prummer O., Frickhofen N., Digel W., Heimpel H. & Porzsolt F. (1991) Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Ann Hematol 62, 76.
12. 12. Trown P., Kramer M., Dennin R.J. et al. (1983) Antibodies to human leukocyte interferons in cancer patients. Lancet I, 81.
13. 13. Mogensen K.E., Daubas P.H., Gresser I., Sereni D. & Varet B. (1981) Patient with circulating antibodies to α-interferon. Lancet ii, 1227.
14. 14. Pozzetto B., Mogensen K.E. & Tovey M.G., I.&.Gresser (1984) Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease. J Infect Dis 150, 707.
15. 15. Ikeda Y., Toda G., Hashimoto N. et al. (1991) Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis. Clin Exp Immunol 85, 80.
16. 16. Fall L.S., Chams V., Le-Coq H. et al. (1995) Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infection. Cell Mol Biol Noisy Grand 41, 409.
17. 17. Prummer O., Bunjes D., Wiesnetii M. et al. (1996) Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation. Bone Marrow Transplant 17, 617.
18. 18. Meager A., Willcox N., Vincent A. & Newsom-Davis J. (1997) Spontaneous neutralizing antibodies to interferon-alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet 350, 1596.
19. 19. Meager A., Wadhwa M., Bird C. et al. (1999) Spontaneously occurring neutralizing antibodies against Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in patients with autoimmune disease. Immunology 97, 526.
20. 20. Svenson M., Hansen M.B., Ross C. et al. (1998) Antibody to Granulocyte-Macrophage Colony-Stimulating Factor is a dominant anti-cytokine activity in human IgG preparations. Blood 91, 2054.
21. 21. Bendtzen K., Hansen M.B., Ross C. & Svenson M. (1998) High-avidity autoantibodies to cytokines. Immunol Today 19, 209.
22. 22. Denys C., Toungouz M. & Dupont E. (1997) Increased in vitro immunsuppressive action of anti-CMV and anti-HBs intravenous immunoglobulins due to higher amounts of interferon-gamma specific neutralizing antibodies. Vox Sang 72, 247.
23. 23. Wadhwa M. & Thorpe R. (1998) Assays for Cytokines. In: The Cytokine Handbook (ed. A. Thomson), 3rd edn, p. 855. Academic Press, London.
24. 24. Wadhwa M., Bird C., Fagerberg J. et al. (1996) Production of neutralizing GM-CSF antibodies in carcinoma patients following GM-CSF combination therapy. Clin Exp Immunol 104, 351.
25. 25. Däubener W., Wanagat N., Pilz K. et al. (1994) A new, simple, bioassay for human IFN-γ. J Immunol Methods 168, 39.
26. 26. Wadhwa M., Hjelm Skog A.L., Bird C. et al. (1999) Immunogenicity of GM-CSF products in patients undergoing combination therapy with GM-CSF. Clin Can Res 5, 1353.
27. 27. Johnstone A.P. & Thorpe R. (1997). Immunochemistry in Practice 3rd edn. Blackwell Scientific, Oxford.
28. 28. Ross C., Svenson M., Hansen M.B., Vejlsgaard G.L. & Bendtzen K. (1995) High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest 95, 1974.
29. 3U/ml of interleukin 2. J Immunol Methods 99, 7.
30. 30. Meager A. (1998) Interferons alpha, beta and omega. In: Cytokines (eds A.R. Mire-Sluis & R. Thorpe), p. 361. Academic Press, London.
31. 31. Toungouz M., Denys C. & Dupont E. (1996) Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins. Transplantation 62, 1292.
32. 32. Turano A., Balsari A., Viani E. et al. (1992) Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci USA 89, 4447.
33. 33. Sioud M., Dybwad A., Jespersen L. et al. (1994) Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library. Clin Exp Immunol 98, 520.
34. 34. Sylvester I., Yoshimura T., Sticherling M. et al. (1992) Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 90, 471.
35. 35. Van der Meide P.H. & Schellekens H. (1997) Anti-cytokine autoantibodies: epiphenomenon or critical modulators of cytokine action. Biotherapy 10, 39.